Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$326000.0.

  • Bioventus' Other Non Operating Income fell 15207.67% to -$326000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$423000.0, marking a year-over-year decrease of 13800.54%. This contributed to the annual value of $1.6 million for FY2024, which is 2751.94% up from last year.
  • Per Bioventus' latest filing, its Other Non Operating Income stood at -$326000.0 for Q3 2025, which was down 15207.67% from -$561000.0 recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Other Non Operating Income peaked at $1.6 million during Q2 2023, and registered a low of -$9.4 million during Q4 2022.
  • Its 5-year average for Other Non Operating Income is -$524210.5, with a median of -$326000.0 in 2025.
  • Per our database at Business Quant, Bioventus' Other Non Operating Income skyrocketed by 132522.52% in 2021 and then crashed by 113333.33% in 2025.
  • Over the past 5 years, Bioventus' Other Non Operating Income (Quarter) stood at $1.4 million in 2021, then plummeted by 792.21% to -$9.4 million in 2022, then soared by 107.53% to $709000.0 in 2023, then soared by 75.04% to $1.2 million in 2024, then plummeted by 126.27% to -$326000.0 in 2025.
  • Its last three reported values are -$326000.0 in Q3 2025, -$561000.0 for Q2 2025, and -$777000.0 during Q1 2025.